Quantcast

Latest Rome process Stories

2010-06-03 07:00:00

SAN DIEGO, June 3 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial...

2010-05-04 12:59:44

Results confirm earlier Cedars-Sinai studies showing effectiveness of rifaximin against chronic IBS A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug. Researchers found that...

2010-04-06 07:00:00

Functional GI Disorders Are Common, Comprise about 40 percent of GI Diagnoses BETHESDA, Md., April 6 /PRNewswire-USNewswire/ -- New clinical algorithms will give physicians a practical, efficient and cost-effective aid to diagnose the frequent gastrointestinal symptoms that patients commonly bring to their primary care doctors and gastroenterologists--symptoms of functional GI disorders that are often difficult to diagnose. Developed by the Rome Foundation and published in the April issue...

2010-04-05 07:00:00

WALTHAM, Mass., April 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that thought leaders believe Prometheus's Lotronex has efficacy advantages over current and emerging therapies for non-constipation predominant irritable bowel syndrome but side effects associated with the drug limit its use. Surveyed primary care physicians say that a therapy's effect on overall irritable bowel syndrome symptoms...

2010-03-18 14:02:28

IBS, abdominal pain more common in nurses working rotating shifts Nurses participating in shift work, especially those working rotating shifts, face a significantly increased risk of developing Irritable Bowel Syndrome (IBS) and abdominal pain compared to those working a standard day-time schedule, according to research published in the American Journal of Gastroenterology. "We know that people participating in shift work often complain of gastrointestinal symptoms such as abdominal pain,...

2010-01-15 17:58:00

Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology. A research article to be published on December 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team from Finland quantified fourteen bacterial phylotypes which corresponded with bacterial species of...

2009-08-12 11:24:25

IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. TCAs have been shown to improve abdominal pain in patients with IBS; however, there is insufficient evidence of global symptom relief. The search for an optimal treatment to improve symptoms and quality of life in IBS remains ongoing.A research article to be published on August 7, 2009 in the World Journal of Gastroenterology addresses this question. In the...

2009-07-22 09:33:18

Although visceral hypersensitivity is considered a hallmark feature of IBS, conflicting evidence exists regarding somatic hypersensitivity in this patient population. Several investigators have found no evidence for heightened somatic pain sensitivity in IBS patients. Also, others have reported similar cold presser pain tolerance in IBS patients and controls. These conflicting findings may result from differing somatic pain testing procedures. Previous studies have explored the correlates of...

2009-06-01 07:10:00

MEBANE, N.C., June 1 /PRNewswire/ -- Behavioral Health Associates of NC, Inc. announces the release for sale of the iPhone symptom tracker application for Irritable Bowel Syndrome. This application helps users keep track of bowel function as well as ten other variables in order to create an accurate picture of IBS symptom experience. The application prepares 24 hour, one week and 90 day graphs of symptoms and can e-mail these graphs along with a text summary to any e-mail address of the...

2009-05-31 10:45:00

-- Data Presented Today at DDW Demonstrate Linaclotide Provided Early Onset of Abdominal Pain Relief and Improved Bowel Habits -- CAMBRIDGE, Mass. and NEW YORK, May 31, 2009 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced results from additional analyses of their Phase 2b study assessing the safety and efficacy of the novel, first-in-class agent linaclotide in 419 patients with irritable bowel syndrome with constipation...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related